Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H6AsCl2NO.ClH |
| Molecular Weight | 290.406 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC1=C(O)C=CC(=C1)[As](Cl)Cl
InChI
InChIKey=LOYXLMNYVHOJJJ-UHFFFAOYSA-N
InChI=1S/C6H6AsCl2NO.ClH/c8-7(9)4-1-2-6(11)5(10)3-4;/h1-3,11H,10H2;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C6H6AsCl2NO |
| Molecular Weight | 253.946 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dichlorophenarsine is a potent anti-syphilitic drug, which exhibits a rapid effect on the serological reactions of the blood in early syphilis. Dichlorophenarsine was more rapid than thiacetarsamide sodium in its action against the canine heartworms infections. Dichlorophenarsine was used for the treatment of canine filariasis - emesia, nausea, and shock occurred several to 30 minutes after injection. Ascorbic acid and hesperidin methyl chalcone when used as a combined therapy afforded a definite protection in mice against the toxic effect of a single dose of intravenously administered dichlorophenarsine hydrochloride.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:39 GMT 2025
by
admin
on
Mon Mar 31 18:20:39 GMT 2025
|
| Record UNII |
571850CM3R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C254
Created by
admin on Mon Mar 31 18:20:39 GMT 2025 , Edited by admin on Mon Mar 31 18:20:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
571850CM3R
Created by
admin on Mon Mar 31 18:20:39 GMT 2025 , Edited by admin on Mon Mar 31 18:20:39 GMT 2025
|
PRIMARY | |||
|
536-29-8
Created by
admin on Mon Mar 31 18:20:39 GMT 2025 , Edited by admin on Mon Mar 31 18:20:39 GMT 2025
|
PRIMARY | |||
|
4663
Created by
admin on Mon Mar 31 18:20:39 GMT 2025 , Edited by admin on Mon Mar 31 18:20:39 GMT 2025
|
PRIMARY | |||
|
68301
Created by
admin on Mon Mar 31 18:20:39 GMT 2025 , Edited by admin on Mon Mar 31 18:20:39 GMT 2025
|
PRIMARY | |||
|
m689
Created by
admin on Mon Mar 31 18:20:39 GMT 2025 , Edited by admin on Mon Mar 31 18:20:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
C75248
Created by
admin on Mon Mar 31 18:20:39 GMT 2025 , Edited by admin on Mon Mar 31 18:20:39 GMT 2025
|
PRIMARY | |||
|
DTXSID80201816
Created by
admin on Mon Mar 31 18:20:39 GMT 2025 , Edited by admin on Mon Mar 31 18:20:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |